Terbaru

  • Bitcoin S (BTCS)

    The Bitcoin S (BTCS) transactionchain will integrate the value of public chain to build a global value transfer network. The CBNData data report shows that among the 120 annual consumer buzzwords in the five years from 2016 to 2020, blockchain ranks among the top. Recently, the BTCS transactionchain wallet has attracted the attention of many capital and media in the circle with its fast, safe tran
  • BYD Wins the Largest Pure-Electric Bus Order outside of China

    Bogotá, Colombia - BYD is proud to announce that it has exclusively won cumulative orders to supply 1,002-unit pure-electric buses to the capital of Colombia, Bogotá. This tender was open to all bus technologies, yet BYD won the trust and cooperation of its partners in the fiercely competitive bidding process thanks to its cutting-edge technologies, products and services. This is the largest order
  • Dab the 5G Era with the Perfume of Books and Fragrance of Ink — allow full rein to a better life with Hisense A7

    On Dec 22nd, Hisense’s new reading flagship cellphone A7 series was officially launched. This series is the continuation of the characteristics of Hisense A series' most typical ink screen design, namely e-ink screen, a kind of screen that uses electronic ink, which is also known as e-paper displays. This is the world's first 5G cellphone equipped with an ink screen, marking the official arrival o
  • BYD Delivers Largest Pure Electric Bus Fleet in Colombia

    Bogota, Colombia - On December 17, BYD announced the delivery of 470 pure electric buses to Bogota, the capital of Colombia. This is the country’s largest pure electric bus fleet, and also the largest bus fleet BYD has delivered in the Americas, which will effectively promote the already fast-growing electrified public transport systems in Colombia, Latin America and the entire Americas.
  • THE 9 th RESIDENCE | NEWERA DESIGN

    THE 9 th RESIDENCE "Break the cocoon and become a butterfly"Full record
  • Great News: a Special Drug from China for the treatment of novel coronavirus

    Duan Zhitang (Beijing) International Pharmaceutical Technology Development Co., Ltd. was founded in June 2009, the company has been committed to the inheritance and promotion of traditional Chinese medicine culture, focusing on the development and application of court secret recipe antiviral products, we have achieved a number of scientific and technological achievements in the field of antivirus,
  • Kewangan terdesentralisasi menambah ahli baru: sistem pengurusan kewangan P2P yang pertama diedarkan di dunia sangat dalam talian

    Desentralisasi adalah teknologi konsensus yang sangat baik untuk manusia, DeFi adalah aplikasi blockchain yang paling hebat, dan badan konsensus super siput adalah yang paling banyak Platform kewangan terdesentralisasi yang hebat. Ia menyediakan sistem pengurusan kewangan P2P yang diedarkan dengan mudah dan selamat untuk pengguna global. Ia dikembangkan secara bebas oleh pemain blockchain. Ia bena
  • The 2020 OCS to take new forms through upgrading

    The 2020 Convention on Exchange of Overseas Talents and the 22nd Guangzhou Convention of Overseas Chinese Scholars in Science and Technology (hereinafter referred to as the 2020 OCS) will be held from December 18 to 19 in Guangzhou, co-hosted by the Ministry of Education, Western Returned Scholars Association and Guangzhou Municipal Government and coordinated jointly by 29 cities including Beijing
  • Bityard exchange has obtained crypto financial licenses issued by multiple authorities

    Abstract: Bityard has obtained two crypto financial licenses issued by the Estonia Financial Supervision Authority (MTR), and will keep focusing on providing safe and reliable crypto trading services to the investors around the world.
  • Perdagangan salinan Bityard menjadikan perdagangan kontrak kripto lebih mudah

    Baru-baru ini, harga Bitcoin, salah satu daripada mata wang kripto arus utama di pasaran, mencapai $19,000. Pada masa yang sama, harga Ethereum juga melepasi $600 minggu lepas. Walaupun harga kebanyakan mata wang kripto telah menurun sedikit semenjak kebelakangan ini, pasaran masih sesak dengan peniaga dan pelabur.

Pautan mesra

Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic

04-10    

On April 4, 2020, Phoenix TV broadcast a report on Yiling Pharmaceutical. It was reported that the global epidemic continued to worsen. At the China-Europe anti-epidemic exchange meeting, the recovery rate of patients treated with Lianhua Qingwen Capsule of Yiling Pharmaceutical co., LTD was as high as 91.5 percent, which has become a hot spot. Since 2004, Lianhua Qingwen Capsule has been listed by the national health commission of China, the state administration of traditional Chinese medicine and other departments in the treatment of influenza and other respiratory diseases for more than 20 times. It has played an important role in the prevention and control of major epidemics. On March 30, Lianhua Qingwen Capsule was approved by the ministry of health of Thailand for the registration of modern herbal medicine, which indicated that Yiling pharmaceutical co., a representative of modern Chinese medicine enterprises in China, had the qualification to sell Lianhua Qingwen Capsule as a drug in the Thai market.

Lianhua Qingwen Capsule helps prevent and control the global epidemic


At the beginning of 2020, COVID - 19 outbreak occurred in Wuhan, China, as the medicine recommended by the national health commission of China in the "diagnosis and treatment scheme of pneumonia infected by novel coronavirus", the market demand of Lianhua Qingwen capsules (granules) produced by Yiling Pharmaceutical co., LTD surged. In order to ensure market supply and help prevent and control the epidemic, all the production lines of Yiling Pharmaceutical co., ltd. are racing against time to produce Lianhua Qingwen products within 24 hours." When the outbreak came, we immediately donated 10 million yuan of Lianhua Qingwen capsules to the Red Cross society of China, of which 5 million yuan of Lianhua Qingwen capsules were transported overnight to the epidemic area in Wuhan to ensure the market demand. At the same time, we also donated products to foreign countries, such as Iraq and Italy. Yiling Pharmaceutical general manager Wu Xiangjun said in an interview.

In the covid-19 prevention and control programs successively released by more than 20 provinces and cities including Hubei, Guangzhou, Zhejiang, Shandong and Hebei, Lianyanghua Qingwen capsules (granules) are recommended. In an interview, Jia zhenhua, director of the Yiling medical research institute, pointed out that "the formula of Lianhua Qingwen is to include the pathogenesis of such diseases as exogenous febrile diseases (respiratory diseases caused by viruses in western medicine) and its treatment drugs."


The good curative effect of Lianhua Qingwen capsule is due to its characteristic of active intervention in multi-target therapy. Hou Yunlong, deputy director of the new drug evaluation center of Yiling medical research institute, told the reporter: "We found that Lianhua Qingwen has certain antiviral replication ability at the cell. When the virus infects the host cell, the host cell will have a certain immune response, and this immune response will release a number of pro-inflammatory factors.”

The overseas business layout of Yiling keeps accelerating

While actively promoting the fight against the "epidemic", Yiling Pharmaceutical's overseas business layout is also accelerating. On March 30, Yiling pharmaceutical announced that it had obtained the approval from the ministry of health of Thailand for the registration of modern herbal medicine, and approved Lianhua Qingwen capsules to comply with the registration of Thailand's modern herbal medicine standards, which brought more international recognition to traditional Chinese medicine.

"Through this outbreak, there has been a significant change in western European and American countries' understanding of traditional Chinese medicine." Zhao Shaohua, deputy general manager of Yiling Pharmaceutical co., said in an interview, "Lianhua Qingwen has been sold in some countries for many years. It used to be mainly used to treat flu, and there was a normal sale every year. Following the global outbreak of covid-19 this year, the demand for Lianhua Qingwen has increased exponentially. This has laid a very good foundation for Lianhua Qingwen 's future sales in the international market.

At present, Yiling Pharmaceutical products such as Tongxinluo capsule, Lianhua Qingwen capsule, Shensong Yangxin capsule, Qiliqiangxin capsule, Yangzheng Xiaoji capsule have been registered and sold in Korea, Vietnam, Russia, Canada, Singapore, Indonesia and other countries. Tongxinluo capsule has also been included in Vietnam's national health insurance directory. Lianhua Qingwen capsule has been registered in Hong Kong and Macao, as well as in Canada, Mozambique, Indonesia, Brazil, Romania, Thailand and other countries, and has carried out phase II clinical study in the United States.

On the internationalization of traditional Chinese medicine, Wu Xiangjun told reporters: "Yiling Pharmaceutical has set up the world federation of traditional Chinese medicine collateral disease branch, as well as in Canada, Europe, northern Europe. The theory of collateral disease has become a window for the world to understand the culture of traditional Chinese medicine, and a bright spot for the culture of traditional Chinese medicine to enter the world. With the deepening of people's understanding of traditional Chinese medicine and its wide spread, I believe traditional Chinese medicine will be a bright name card for China's internationalization in the future."



Penafian: Artikel ini diterbitkan semula dari media lain. Tujuan mencetak semula adalah untuk menyampaikan lebih banyak maklumat. Ini tidak bermakna laman web ini bersetuju dengan pandangannya dan bertanggungjawab ke atas keasliannya, dan tidak menanggung tanggungjawab undang-undang. Semua sumber di laman web ini dikumpulkan di Internet. Tujuan perkongsian adalah untuk pembelajaran dan rujukan sahaja. Sekiranya terdapat pelanggaran hak cipta atau harta intelek, sila tinggalkan mesej.
Kembali ke atas
© Hak cipta 2009-2020 Ekspres Kewangan Melayu      Hubungi kami   SiteMap